Skip to content
DataLookout
Menu

NCT06702774

Research on Key Interventional Technologies for Controlling the Epidemic in High-prevalence Areas of Tuberculosis in Guangxi, China

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 3 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion date changed from estimate of Jan 31, 2025 to Jul 31, 2025 Show 5 more changesShow less
    • Eligibility criteria expanded, about 4 words
    • Trial completed
    • Final enrollment: 43067 participants (planned 72000)
    • Site details revised
    • Publications: details revised at 1 of 1 entry
  2. Notable Trial status: Active, Not Recruiting to Recruiting
    • Primary completion date: Oct 21, 2024 to Jan 31, 2025
    • Study completion date: Mar 31, 2025 to Apr 30, 2025
    • Site details revised
    v3
  3. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Prevalence rate of bacteriologically positive TB
Timeframe: In year 3 after recruitment

Secondary (3)

Prevalence rate of active TB
Notification rates of bacteriologically positive TB
Notification rates of active TB cases

Arms and interventions

InterventionExperimental

A single active case finding campaign for Tuberculosis will occur in Year 1 alongside the usual care.

ControlNo intervention

Usual care will be provided and no active case finding activities will be implemented.

Diagnostic tests: Active case finding

Sites

1 site in 1 country

  • Guangxi Zhuang Autonomous Region Center for Disease Control and PreventionNanning, Guangxi, China